Product site
RX PLATFORM ORIGIN Tallinn, EE FORM point-of-prescription decision support REV. 2026

Every prescription carries a warning label.
Most of them just aren't printed yet.

Dosia checks a patient's genetic profile against the drug being prescribed and flags the risk before the medication ever reaches the pharmacy counter.

See a live check
Built in Europe Backed by Estonia's Biobank infrastructure
Point-of-prescription check● live
⚠ Reduced antiplatelet effect
CYP2C19 poor metaboliser — clopidogrel may not convert to its active form. CPIC recommends an alternative such as prasugrel or ticagrelor.
Gene
CYP2C19
Diplotype
*2/*2
CPIC level
A